Design of smart linkers and their applications in controlled-release drug delivery systems
Antibody drug conjugates (ADC) represents an interesting strategy in tumour targeted therapy . The approach is based on the combination of the high affinity of an antibody towards its antigen and the high cytotoxicity of a drug, leading to a selective therapuetic agent with improved efficacy and saf...
Guardado en:
Autor principal: | Ferhati, Xhenti |
---|---|
Otros Autores: | Corzana López, Francisco (null) |
Formato: | text (thesis) |
Lenguaje: | eng |
Publicado: |
Universidad de La Rioja (España)
2019
|
Acceso en línea: | https://dialnet.unirioja.es/servlet/oaites?codigo=252736 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent advances in "smart" delivery systems for extended drug release in cancer therapy
por: Kalaydina RV, et al.
Publicado: (2018) -
Controlled release of simvastatin from biomimetic β-TCP drug delivery system.
por: Joshua Chou, et al.
Publicado: (2013) -
Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs
por: Konstantinos E. Papathanasiou, et al.
Publicado: (2017) -
Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
por: Kasiński A, et al.
Publicado: (2020) -
Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?
por: Hoseini-Ghahfarokhi M, et al.
Publicado: (2020)